Low risk of intracranial and systemic hemorrhages in patients on dual antiplatelet treatment beyond 1 month following neuroendovascular angioplasty and/or stent placement.

作者: Ameer E. Hassan , Haralabos Zacharatos , Gabriela Vazquez , Gustavo J. Rodriguez , M. Fareed K. Suri

DOI: 10.1111/J.1552-6569.2010.00520.X

关键词: Adverse effectAngioplastyStrokeStentDiscontinuationIncidence (epidemiology)ClopidogrelAspirinSurgeryMedicine

摘要: BACKGROUND Aspirin and clopidogrel treatment beyond 1 month in patients undergoing angioplasty and/or stent placement within the extra- intracranial arteries is not defined. OBJECTIVE To determine incidence of systemic bleeding events, recurrent ischemic stroke, death treated with dual antiplatelets for greater than month. METHODS We determined rates hemorrhage, or consecutive lesions, after procedures. RESULTS Dual antiplatelet was initiated 110 following endovascular a median time period 3 months (364 person-months exposure). There were two events (1 gastrointestinal), no deaths. The rate due to premature discontinuation 8.3 per 1,000 (95%, CI [2.7-25.6]). first treatment. CONCLUSION We did find an increased risk adverse procedure, supporting safety intermediate-term as adjunct intra- extracranial placement.

参考文章(40)
Colin P. Derdeyn, Marc I. Chimowitz, Angioplasty and Stenting for Atherosclerotic Intracranial Stenosis: Rationale for a Randomized Clinical Trial Neuroimaging Clinics of North America. ,vol. 17, pp. 355- 363 ,(2007) , 10.1016/J.NIC.2007.05.001
F.M. McKevitt, M.S. Randall, T.J. Cleveland, P.A. Gaines, K.T. Tan, G.S. Venables, The Benefits of Combined Anti-platelet Treatment in Carotid Artery Stenting European Journal of Vascular and Endovascular Surgery. ,vol. 29, pp. 522- 527 ,(2005) , 10.1016/J.EJVS.2005.01.012
Ameer E Hassan, Haralabos Zacharatos, M Fareed, K Suri, Adnan I Qureshi, Drug evaluation of clopidogrel in patients with ischemic stroke. Expert Opinion on Pharmacotherapy. ,vol. 8, pp. 2825- 2838 ,(2007) , 10.1517/14656566.8.16.2825
Adnan I. Qureshi, Edward Feldmann, Camilo R. Gomez, S. Claiborne Johnston, Scott E. Kasner, Donald C. Quick, Peter A. Rasmussen, M. Fareed K. Suri, Robert A. Taylor, Osama O. Zaidat, Consensus Conference on Intracranial Atherosclerotic Disease: Rationale, Methodology, and Results: Views and Reviews Journal of Neuroimaging. ,vol. 19, ,(2009) , 10.1111/J.1552-6569.2009.00414.X
Steven R. Steinhubl, Peter B. Berger, J. Tift Mann III, Edward T. A. Fry, Augustin DeLago, Charles Wilmer, Eric J. Topol, for the CREDO Investigators, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. ,vol. 288, pp. 2411- 2420 ,(2002) , 10.1001/JAMA.288.19.2411
Christopher M Goods, Ming W Liu, Sriram S Iyer, Jay S Yadav, Khaled F Al-Shaibi, Larry S Dean, Gary S Roubin, A Cost Analysis of Coronary Stenting Without Anticoagulation Versus Stenting With Anticoagulation Using Warfarin The American Journal of Cardiology. ,vol. 78, pp. 334- 336 ,(1996) , 10.1016/S0002-9149(96)00287-1
David Holmes, Amir Lerman, Charanjit Rihal, Gurpreet Sandhu, Brendan Doyle, Ripudamanjit Singh, Malcolm Bell, John Bresnahan, Verghese Mathew, Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up. American Journal of Cardiology. ,vol. 99, pp. 465- 469 ,(2007) , 10.1016/J.AMJCARD.2006.08.058
Pilar Jiménez-Quevedo, Dominick J. Angiolillo, Esther Bernardo, Manel Sabaté, Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance? Catheterization and Cardiovascular Interventions. ,vol. 62, pp. 39- 42 ,(2004) , 10.1002/CCD.10756
Eugène P McFadden, Eugenio Stabile, Evelyn Regar, Edouard Cheneau, Andrew TL Ong, Timothy Kinnaird, William O Suddath, Neil J Weissman, Rebecca Torguson, Kenneth M Kent, August D Pichard, Lowell F Satler, Ron Waksman, Patrick W Serruys, Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. The Lancet. ,vol. 364, pp. 1519- 1521 ,(2004) , 10.1016/S0140-6736(04)17275-9